You're reading the free version. Trader adds the live tape and alerts.
Start tracking
ELVN Exercise Disclosure
Derynck Mika K · SEC Form 4 · Filed Aug 6, 2026
Exercise
Calculated transaction value
$346.96K
Derynck Mika K Director
ELVN
Enliven Therapeutics
ELVN
Transaction date
Aug 4, 2026
Public filing date
Aug 6, 2026
Filing lag
Filed 2 days later
ELVN daily price context
Close on/before transaction
$61.11
Aug 4, 2026
First close after public filing
$60.46
Aug 7, 2026
30-day return after filing
-1.8%
Through Sep 8, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 23,364 shares @ $14.85
- SEC ownership
- Direct
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0001865125-26-000004
Filing cohort
Transactions in this filing
Showing 9 of 9
Trades
9
Issuers
1
Estimated value
$11.28M
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Enliven Therapeutics, Inc. ELVN | Exercise | Aug 4, 2026 | $0 |
| Enliven Therapeutics, Inc. ELVN | Exercise | Aug 4, 2026 | $696.89K |
| Enliven Therapeutics, Inc. ELVN | Sale | Aug 4, 2026 | $9.56M |
| Enliven Therapeutics, Inc. ELVN | Exercise | Aug 4, 2026 | $0 |
| Enliven Therapeutics, Inc. ELVN | Exercise | Aug 4, 2026 | $0 |
| Enliven Therapeutics, Inc. ELVN Current | Exercise | Aug 4, 2026 | $346.96K |
| Enliven Therapeutics, Inc. ELVN | Exercise | Aug 4, 2026 | $460.43K |
| Enliven Therapeutics, Inc. ELVN | Exercise | Aug 4, 2026 | $0 |
| Enliven Therapeutics, Inc. ELVN | Exercise | Aug 4, 2026 | $216.69K |